NWK Group’s DexCom DXCM Stock Holding History

NWK Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,786	Closed	-$1.79M	–	72
2022 Q4	$1.79M	Buy	+15,786	New	+$1.73M	1.32%	29
2020 Q4	–	Sell	-15,812	Closed	-$1.63M	–	206
2020 Q3	$1.63M	Buy	15,812 +572	+4%	+$59.8K	0.8%	42
2020 Q2	$1.54M	Buy	+15,240	New	+$1.36M	0.88%	37

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

NWK Group's DXCM Position: Q1 2023 in Review

NWK Group sold out of DexCom (DXCM) in Q1 2023, closing a stake of 15,786 shares — an estimated $1.79M sold.

NWK Group first reported a position in DXCM in Q2 2020 and held it in 3 quarters. The position peaked at $1.79M in Q4 2022. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

NWK Group reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
NWK Group sold 15,786 DexCom shares in Q1 2023, an estimated $1.79M.
NWK Group first reported a position in DexCom in Q2 2020 and held it in 3 quarters.
NWK Group's DexCom position peaked at $1.79M in Q4 2022.
904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on NWK Group's 13F filing for Q1 2023, filed 15 May 2023.